Acrinova AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 37.8 million compared to SEK 34.25 million a year ago. Revenue was SEK 38.33 million compared to SEK 37.67 million a year ago. Net loss was SEK 14.3 million compared to net income of SEK 4.95 million a year ago. Basic loss per share from continuing operations was SEK 0.21 compared to basic earnings per share from continuing operations of SEK 0.08 a year ago.
For the full year, sales was SEK 143.35 million compared to SEK 122.44 million a year ago. Revenue was SEK 147.08 million compared to SEK 130.53 million a year ago. Net income was SEK 7.76 million compared to SEK 79.34 million a year ago. Basic earnings per share from continuing operations was SEK 0.11 compared to SEK 1.23 a year ago.